Predictive Value of SYNTAX Score in Risk Stratification of Patients Undergoing Unprotected Left Main Coronary Artery Angioplasty

Volume 23 - Issue 12 - December 2011
Posted on: 12/1/11
0 Comments
7135 reads

Author(s):

João Brito, MD, Rui Teles, MD, Manuel Almeida, MD, Pedro de Araújo Gonçalves, MD, Luis Raposo, MD, Pedro Sousa, MD, Miguel Mendes, MD

References

Yusuf S, Zucker D, Peduzzi P, et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet. 1994;344(8922):563-570.
O’Keefe JH Jr, Hartzler GO, Rutherford BD, et al. Left main coronary angioplasty: early and late results of 127 acute and elective procedures. Am J Cardiol. 1989;64(3):144-147.
Lee MS, Yang T, Doot J, Liao H. Meta-analysis of clinical studies comparing coronary artery bypass grafting with percutaneous coronary intervention and drug-eluting stents in patients with unprotected left main coronary artery narrowings. Am J Cardiol. 2010;105(8):1070-1075.
Kim YH, Dangas GD, Solinas E, et al. Effectiveness of drug-eluting stent implantation for patients with unprotected left main coronary artery stenosis. Am J Cardiol. 2008;101(6):801-806.
Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360(10):961-972.
Sianos A, Morel MA, Kappentein AP, et al. The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention. 2005;1(2):219-227.
Ong ATL, Serruys PW, Mohr FW, et al. The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase. Am Heart J. 2006;151(6):1194-1204.
Wijns W, Kolh P, Danchin N, et al; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS); European Association for Percutaneous Cardiovascular Interventions (EAPCI). Guidelines on myocardial revascularization. Eur Heart J. 2010;31(20):2501-2555.
Valgimigli M, Serruys PW, Tsuchida K, et al. Cyphering the complexity of coronary artery disease using the SYNTAX score to predict clinical outcome in patients with three-vessel lumen obstruction undergoing percutaneous coronary intervention. Am J Cardiol. 2007;99(8):1072-1081.
Kim Y-H, Park D-W, Kim W-J, et al. Validation of SYNTAX (Synergy between PCI with TAXUS and Cardiac Surgery) scores for prediction of outcomes after unprotected left main coronary revascularization. JACC Cardiovasc Interv. 2010;3(6):612-623.
Capodano D, Di Salvo ME, Cincotta G, et al. Usefulness of the SYNTAX score for predicting clinical outcome after percutaneous coronary intervention of unprotected left main coronary artery disease. Circ Cardiovasc Interv. 2009;2(4):302-308.
Singh M, Peterson ED, Milford-Beland S, Rumsfeld JS, Spertus JA. Validation of the Mayo Clinic risk score for in-hospital mortality after percutaneous coronary interventions using the National Cardiovascular Data Registry. Circ Cardiovasc Interv. 2008;1(1):36-44.
Madan P, Elayda MA, Lee V, Wilson JM. Predicting major adverse cardiac events after percutaneous coronary intervention: the Texas Heart Institute risk score. Am Heart J. 2008;155(6):1068-1074.
Capodano D, Miano M, Cincotta G, et al. EuroSCORE refines the predictive ability of SYNTAX score in patients undergoing left main percutaneous coronary intervention. Am Heart J. 2010;159(1):103-109.